Table 1

 Baseline characteristics of patients with a history of extracardiac vascular disease (ECVD) in the CREDO trial stratified by clopidogrel use

Clopidogrelp Value
− (n = 140)+ (n = 132)
Data are mean (SD) or percentages.
ACE, angiotensin converting enzyme inhibitor; MI, myocardial infarction; PCI, percutaneous coronary intervention.
Age (years)65.4 (10.3)67.9 (9.4)0.032
Women33.5%34.1%0.928
Weight (kg)86.1 (19.6)83.7 (19.1)0.212
Body mass index >3041.7%37.2%0.438
Risk factors
    Prior MI37.5%35.1%0.692
    Diabetes32.3%32.5%0.972
    Hypertension75.7%76.3%0.905
    Smoking (within past year)32.8%27.3%0.330
    Family history of heart disease47.1%48.6%0.804
    Hyperlipidaemia71.8%76.5%0.383
Baseline medications
    Aspirin28.6%34.1%0.326
    β Blocker65%63.6%0.814
    Statin58.5%61.3%0.639
    ACE inhibitor34.3%40.9%0.259
    Calcium channel blocker46.4%37.1%0.120
Treatment after initial angiogram
    PCI84.8%91.650.088
    Medical treatment5%0%0.015
    Bypass surgery3.57%3.79%1.000
Indications for PCI
    Recent MI5.1%8.5%0.124
    Unstable angina62.7%50.8%0.124
    Stable angina32.1540.7%0.124